Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Clinical and Prognostic Significance of CEBPA Mutations in Myelodysplastic Syndromes.
Journal: Cancers
Published: June 06, 2026
From episodic assessment to comprehensive assessment: integrating real-world monitoring in relapsed/refractory multiple myeloma.
Journal: Expert review of hematology
Published: May 27, 2026
The ClinicalTrials.gov Landscape of Multiple Myeloma Clinical Trials: A 20-Year Analysis of Geographic Distribution and Growth Patterns: USMIRC Analysis.
Journal: Current oncology (Toronto, Ont.)
Published: May 05, 2026
Mezigdomide, carfilzomib, and dexamethasone versus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma (SUCCESSOR-2): a phase 3, open-label, randomised controlled trial.
Journal: Lancet (London, England)
Published: April 29, 2026
Evaluation of Real-World Studies on Management of Relapsed Multiple Myeloma After BCMA-Directed Therapy Failure from U.S. Academic Centers and USMIRC.
Journal: Current oncology (Toronto, Ont.)
Published: March 17, 2026
High-Risk Cytogenetic Multiple Myeloma Remains a Therapeutic Challenge: A 15-Year Real-World Analysis.
Journal: Current oncology (Toronto, Ont.)
Published: March 11, 2026
Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients.
Journal: Current oncology (Toronto, Ont.)
Published: March 09, 2026
Maintenance Strategies in High-Risk Myeloma: A Multicenter Comparison of Bortezomib-Lenalidomide Versus Lenalidomide Alone: A USMIRC Multicenter Analysis.
Journal: Current oncology (Toronto, Ont.)
Published: January 30, 2026
Prognostic significance of CUX1 genomic deletion in myelodysplastic neoplasms.
Journal: Annals of hematology
Published: December 30, 2025
Prognostic significance of KRAS G12C versus non-G12C RAS mutations in metastatic colorectal cancer: a systematic review and meta-analysis.
Journal: The oncologist
Published: November 11, 2025
Teclistamab Dosing Strategies in Relapsed/Refractory Myeloma: A Real-World Comparison of Weekly and Biweekly Versus Fixed Intervals.
Journal: Cancers
Published: September 19, 2025
Urinary Stricture due to Localized Urethral AL Amyloidosis: A Case Report and Literature Review.
Journal: Case reports in oncology
Published: May 29, 2025
Last Updated: 09/26/2026